Feed / ABVX

ABIVAX Société Anonyme

ABVX

Healthcare · 115.07 -2.8% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

ABIVAX Société Anonyme's move is being confirmed by its market group.

ABVX accounts for 29.3% of the group's measured movement across 3.9 effective names. raw member direction is mixed; 3 of 5 session-normalized paths align to the downside. Capital-flow agreement is 29%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveDominant mover#2 of 5 by movement share
Group movement share29.3%Absolute path energy—not portfolio weight
Relative path-2.54%aligned
Effective breadth3.9 / 5balanced
Relative alignment3/5downside path · 2 counter-moving
Capital-flow agreement29%not yet clean
SEQUENCE READ

CELC, RVMD, BCRX moved materially before ABVX. ABVX crossed its material path threshold at 14:25 ET, 295 minutes after the first measured mover.

EVIDENCE COVERAGE

5 of 5 members in Clinical Biotechnology are active. 0 of 1 disclosed connections are confirming.

What would change this read
  • At least 4 of 5 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ABCL begins moving with the group.

Invalidation: The live read weakens if participation falls to 1 of 5 members or fewer.

Watch this read

Who this business touches

The relationships behind ABVX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depended on by

ANABAnaptysBio, Inc.competitorNov 4, 2025 ▾

“Commercial-stage competitors in moderate-to-severe ulcerative colitis include monoclonal antibodies targeting anti-TNF (Humira; Abbvie and Remicade; Johnson & Johnson), anti-α4β7 (Entyvio; Takeda), anti-IL-23 (Stelara; Johnson & Johnson, Omvoh; Eli Lilly, Tre…”

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ABVX is currently a Early Follower in the organic co-movement group Clinical Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.